US Single Cell Sequencing Market (2025-2030)
The US Single Cell Sequencing Market was valued at $586.4 Million in 2025 and projected to reach to $1008.1 Million by 2030, representing a compound annual growth rate of 11.4%. The US single cell sequencing market is positioned for sustained expansion through 2030, driven by increasing adoption of precision medicine approaches and the growing need for detailed cellular characterization in cancer research and immunology.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Single Cell Sequencing Market Trends and Insights
- This expansion reflects the US healthcare sector's increasing adoption of advanced genomic technologies for precision medicine, cancer research, and immunology applications.
- The US market benefits from strong R&D investment, established biotech infrastructure, and growing clinical demand for single-cell resolution data. Driving this growth, the US market is witnessing accelerated adoption across academic institutions, pharmaceutical companies, and clinical diagnostics laboratories.
- Between 2025 and 2030, the US is expected to maintain its leadership position in single cell sequencing innovation, supported by favorable reimbursement policies and substantial government funding for genomic research initiatives.
- The US market's 11.4% compound annual growth rate underscores sustained momentum in cell biology research and therapeutic development. Key applications in the US include tumor microenvironment characterization, immune cell profiling, and developmental biology studies.
- The US competitive landscape features both established sequencing platform providers and emerging specialized vendors, driving continuous technological advancement and cost reduction that further accelerates US market penetration..
Key Market Statistics
- CAGR (2025-2030) 11.4% CAGR
- Market Size, 2025 ~USD 586.4 Million
- Forecast, 2030 ~USD 1008.1 Million
- Country US
US Single Cell Sequencing Market Overview
Market Valuation :
The US single cell sequencing market is valued at $586.4 million in 2025, with strong momentum driven by precision medicine initiatives and advanced genomic research adoption across leading academic and commercial laboratories.
Robust Growth Trajectory :
With an 11.4% CAGR through 2030, the US market is projected to reach $1,008.1 million, outpacing many other healthcare technology segments and reflecting sustained investment in cellular-level diagnostics and therapeutics development.
R&D Leadership :
The US maintains a competitive advantage through substantial NIH funding, venture capital investment, and collaboration between biotech firms and research institutions, accelerating innovation in single cell analysis platforms and applications.
Clinical Application Expansion :
Growing adoption in oncology, immunotherapy development, and rare disease diagnosis is driving demand for single cell sequencing technologies among US hospitals, diagnostic centers, and pharmaceutical research organizations.
US Single Cell Sequencing Market Dynamics
- Major pharmaceutical companies and academic medical centers are investing heavily in single cell technologies to accelerate drug discovery and develop targeted therapeutics.
- Regulatory support for advanced diagnostics and reimbursement improvements are expected to further accelerate market penetration across clinical and research settings. Key growth catalysts include the integration of single cell sequencing into routine clinical workflows, declining sequencing costs, and expanding applications in infectious disease and regenerative medicine.
- The US market will benefit from strong intellectual property protections, established biotech ecosystems in major hubs, and continued government funding for genomic research initiatives.
- Competition among platform providers is intensifying, driving technological innovation and accessibility improvements..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- The US single cell sequencing market will grow from $586.4M (2025) to $1,008.1M (2030), representing a 71.8% increase over five years.
- The US maintains an 11.4% CAGR, driven by precision medicine adoption and increased R&D spending in academic and pharmaceutical sectors.
- US market leadership is supported by robust healthcare infrastructure, favorable reimbursement policies, and substantial government genomic research funding.
- Key US applications include tumor microenvironment analysis, immune profiling, and developmental biology, with expanding clinical diagnostics adoption.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
US Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 70.6 | 80 | 86.1 | 95.7 | 108.3 | 125.2 | 148.3 | 179.6 | 15.8 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 63.8 | 72.7 | 78.7 | 88 | 100.2 | 116.5 | 138.7 | 168.9 | 16.5 |
| HOSPITALS & CLINICAL LABORATORIES | 32.9 | 36.4 | 38.4 | 41.7 | 46.2 | 52.2 | 60.4 | 71.3 | 13.2 |
| TOTAL | 167.3 | 189.1 | 203.3 | 225.5 | 254.7 | 293.9 | 347.4 | 419.8 | 15.6 |
US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 243.8 | 245.4 | 250.2 | 265.5 | 290.5 | 326 | 373.1 | 434.2 | 11.7 |
| CROS | 59.5 | 59.1 | 59.5 | 62.4 | 67.4 | 74.6 | 84.3 | 96.8 | 10.2 |
| HOSPITALS & CLINICAL LABORATORIES | 105.9 | 105.7 | 106.9 | 112.5 | 122 | 135.8 | 154.1 | 177.7 | 10.7 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 164.3 | 165.9 | 169.7 | 180.7 | 198.4 | 223.4 | 256.5 | 299.4 | 12 |
| TOTAL | 573.4 | 576.2 | 586.4 | 621 | 678.3 | 759.8 | 868 | 1008.1 | 11.4 |
Target Audience
- Biotech & Diagnostics Companies : US-based and international biotech firms need market intelligence to guide product development, commercialization strategies, and investment in single cell sequencing platforms targeting American research and clinical markets.
- Pharmaceutical R&D Leaders : Drug discovery and development teams require insights into US adoption trends and clinical applications to justify investments in single cell technologies for oncology, immunotherapy, and precision medicine programs.
- Academic & Research Institutions : University research centers and medical schools need market data to support grant applications, justify equipment purchases, and understand the competitive landscape for genomic research capabilities in the US.
- Healthcare Investors & Venture Capitalists : Investment firms focused on US healthcare innovation require validated market sizing and growth forecasts to evaluate funding opportunities in single cell sequencing companies and related technologies.
- Hospital & Diagnostic Laboratory Administrators : Clinical laboratory directors and hospital executives need market insights to assess the business case for implementing single cell sequencing services and understand reimbursement trends in the US healthcare system.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation ($586.4M in 2025) and verified CAGR (11.4%) to support investment decisions, business planning, and competitive positioning in the American single cell sequencing landscape.
- US-Specific Opportunity Assessment : Understand the unique drivers of growth in the US market, including R&D funding patterns, regulatory environment, and clinical adoption rates, enabling targeted market entry and expansion strategies.
- Competitive Intelligence : Benchmark your organization against US market trends and identify gaps in the competitive landscape, helping you develop differentiated products and services for American research and clinical institutions.
- Stakeholder Alignment : Present credible, data-backed market insights to investors, board members, and partners regarding the US single cell sequencing opportunity and long-term revenue potential through 2030.
- Strategic Planning & Forecasting : Leverage US-specific market projections and growth drivers to inform product development roadmaps, sales strategies, and resource allocation decisions for the American healthcare and biotech sectors.
Frequently asked questions
What is the current size of the US single cell sequencing market?
The US single cell sequencing market is valued at $586.4 million in 2025 and is projected to reach $1,008.1 million by 2030.
What is the growth rate of the US single cell sequencing market?
The US single cell sequencing market is growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2030.
What are the primary drivers of growth in the US market?
The US market is driven by increased adoption of precision medicine, substantial R&D investment, government funding for genomic research, and expanding clinical diagnostics applications.
Which sectors are leading adoption of single cell sequencing in the US?
Academic institutions, pharmaceutical companies, biotechnology firms, and clinical diagnostics laboratories are the primary adopters of single cell sequencing technologies in the US.
What applications are most prevalent in the US single cell sequencing market?
The US market is dominated by tumor microenvironment characterization, immune cell profiling, developmental biology research, and emerging clinical diagnostics applications.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
